Europe · Wires & real time · Reuters Business
Pfizer secures up to $1.5 billion from Blackstone for obesity drug development
Detailed summary
Pfizer said on Wednesday that Blackstone would provide up to $1.5 billion through 2028 to help fund the development of an experimental monthly obesity treatment the drugmaker…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)
